Isatuximab 100mg/5ml solution for infusion vials
NHS hospitals in England used £15,416,350 of indicative cost of Isatuximab 100mg/5ml solution for infusion vials in the 12 months to April 2026, about 0.1% of all hospital medicines spend. That is up 17.9% on the previous 12 months.
Indicative cost · 12 months
Quantity (VMP units) · 12 months
Share of hospital medicines spend
Figure 1. Isatuximab 100mg/5ml solution for infusion vials: NHS hospital indicative cost by month (£ millions)
Source: NHSBSA Secondary Care Medicines Data, to April 2026
Cost is indicative — actual hospital medicine prices are commercially confidential, so these figures are estimated from list prices. See methodology.
NHS trusts using Isatuximab 100mg/5ml solution for infusion vials most
By indicative cost over the 12 months to April 2026.
| NHS trust | Indicative cost (12 months) |
|---|---|
| United Lincolnshire Hospitals Nhs Trust | £807,048 |
| University College London Foundation Tr | £739,625 |
| Norfolk & Norwich University Hpl Nhs Trt | £597,682 |
| Western Sussex Hospitals Nhs Found Trust | £543,947 |
| East Kent Hospitals University Nhs Ft | £542,426 |
| University Hospitals Dorset Nhs Ft | £524,683 |
| King's College Hpl Nhs Foundation Trust | £498,322 |
| Ruh Bath Nhs Foundation Trust | £412,142 |
| The Royal Wolverhampton Nhs Trust | £394,399 |
| Univ Hpl B/Ham Nhs Foundation Trust | £365,504 |
The primary-care picture
No confident match to a community-dispensed medicine was found for this product, so no primary-care comparison is shown. SCMD products are recorded at product level, which does not always map cleanly to a BNF substance.